study has found that use of the recombinant zoster vaccine effectively reduces the risk of herpes zoster — more commonly known as shingles — in adults with multiple sclerosis (MS). Specifically, in a retrospective analysis involving more than 14,000 vaccinated people with MS, receiving the recombinant zoster vaccine cut the risk of […]
study has found that use of the recombinant zoster vaccine effectively reduces the risk of herpes zoster — more commonly known as shingles — in adults with multiple sclerosis (MS).
Specifically, in a retrospective analysis involving more than 14,000 vaccinated people with MS, receiving the recombinant zoster vaccine cut the risk of […]
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
study has found that use of the recombinant zoster vaccine effectively reduces the risk of herpes zoster — more commonly known as shingles — in adults with multiple sclerosis (MS). Specifically, in a retrospective analysis involving more than 14,000 vaccinated people with MS, receiving the recombinant zoster vaccine cut the risk of […]
Open the app view to save this story, compare related coverage, and continue from the same source.